Serotonin, via 5-HT(2A) receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

Brain Research

Volumn 825, Issue 1-2, 1999, Pages 161-171

  Aghajanian, George K ^a   Marek, Gerard J ^b  

^a Yale University School of Medicine   (United States)

^b NONE

Author keywords

Apical dendrite; Brain slice; Hallucinogen; Sr2+; Synaptotagmin III; Whole cell recording

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; BICUCULLINE; CALCIUM ION; GLUTAMIC ACID; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT; SEROTONIN; SEROTONIN 2 AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; STRONTIUM; SYNAPTOTAGMIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DENDRITE; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; INTRACELLULAR RECORDING; MALE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; BICUCULLINE; CALCIUM; CALCIUM-BINDING PROTEINS; DENDRITES; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FLUOROBENZENES; FREE RADICAL SCAVENGERS; GABA ANTAGONISTS; GLUTAMIC ACID; INDOPHENOL; MALE; MEMBRANE GLYCOPROTEINS; NERVE TISSUE PROTEINS; ORGAN CULTURE TECHNIQUES; PIPERIDINES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS; RATS, INBRED STRAINS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; STRONTIUM; SYNAPTOTAGMINS;

EID: 0033577494     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01224-X     Document Type: Article

References (33)

1. G.K. Aghajanian, G.J. Marek, Serotonin induces excitatory post-synaptic potentials in apical dendrites of neocortical pyramidal cells, Neuropharmacology 36 (1997) 589-599.
2. 1A receptors mediate opposing responses on membrane excitability in rat association cortex, Neuroscience 40 (1991) 399-412.
3. E.F. Barrett, C.F. Stevens, The kenetics of transmitter release at the frog neuromuscular junction, J. Physiol. (London) 227 (1972) 691-708.
4. M.G. Blanton, J.J. Lo Turko, A.R. Kriegstein, Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex, J. Neurosci. Methods 30 (1989) 203-210.
5. K.R. Bonson, J.W. Buckholtz, D.L. Murphy, Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans, Neuropsychopharmacology 14 (1996) 125-436.
6. P.J. Conn, E. Sanders-Bush, Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site, J. Neurosci. 6 (1986) 3669-3675.
7. 2+ sensor for transmitter release at a central synapse, Cell 79 (1994) 717-727.
8. 2 involvement in the mechanism of action of hallucinogenic agents, Life Sci. 35 (1984) 2502-2511.
9. Y. Goda, C.F. Stevens, Two components of transmitter release at a central synapse, Proc. Natl. Acad. Sci. USA 91 (1994) 12942-12946.
10. 2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken, Molec. Brain Res. 54 (1998) 199-211.
11. I. Herrero, E. Castro, M.T. Miras-Portugal, J. Sanchez-Prieto, Two components of glutamate exocytosis differentially affected by presynaptic modulation, J. Neurochem. 67 (1996) 2346-2354.
12. 2A serotonin receptors in the primate cerbral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites, Proc. Natl. Acad. Sci. USA 95 (1998) 735-740.
13. 2A antagonist with a favorable CNS safety profile, J. Pharmacol. Exp. Ther. 277 (1996) 968-981.
14. 2+ binding properties of synaptotagmins, J. Biol. Chem. 270 (1995) 24898-24902.
15. 2A receptor antagonist, Eur. J. Pharmacol. 259 (1994) 137-141.
16. 2A receptors on neurons in the rat piriform cortex, J. Pharmacol. Exp. Ther. 278 (1996) 1373-1382.
17. G.J. Marek, G.K. Aghajanian, 5-HT-induced EPSCs in neocortical layer V pyramidal cell of prefrontal cortex: suppression by μ opiate receptor activation, Neuroscience 86 (1998) 485-497.
18. 2A receptor-induced EPSCs in layer V pyramidal cells of prefrontal cortex: block by group II/III metabotropic glutamate agonists, Soc. Neurosci. Abs. 24 (1998) 1366.
19. 1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex, Eur. J. Pharmacol., in press (1999).
20. 3 mediated control of dopaminergic function, Psychopharmacology 112 (1993) S60-S67.
21. P. Piguet, M. Galvan, Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro, J. Physiol. (London) 481 (1994) 629-639.
22. H.L. Read, S.G. Beck, N.J. Dun, Serotonergic suppression of interhemispheric cortical synaptic potentials, Brain Res. 643 (1994) 17-28.
23. O. Resnick, D.M. Krus, M. Raskin, LSD-25 action in normal subjects treated with a monoamine oxidase inhibitor, Life Sci. 3 (1964) 1207-1214.
24. J. Schiller, Y. Schiller, G. Stuart, B. Sakmann, Calcium action potentials restricted to distal apical dendrites of rat neocortical pyramidal neurons, J. Physiol. (London) 505 (1997) 605-616.
25. 2-activated interneuron, Brain Res. 506 (1990) 62-69.
26. R.-Y. Shen, R. Andrade, 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus, J. Pharmacol. Exp. Ther. 285 (1998) 805-812.
27. T.C. Sudhof, The synaptic vesicle cycle: a cascade of protein-protein interactions, Nature 375 (1995) 645-653.
28. E. Tanaka, R.A. North, Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex, J. Neurophys. 69 (1993) 1749-1757.
29. 2+ and glutamate release, J. Neurochem. 53 (1989) 1693-1699.
30. 2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens, Psychopharmacology 94 (1988) 213-216.
31. 2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex, J. Neurosci. 17 (1997) 2785-2795.
32. F.X. Vollenweider, K.L. Leenders, C. Scharfetter, P. Maguire, O. Stadelmann, J. Angst, Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis, Neuropsychopharmacology 16 (1997) 357-372.
33. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex, Synapse 27 (1997) 79-82.